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The pathobiology of subclinical pyelonephritis-'--An experimental eval-
uation. Clinical studies have demonstrated a poor correlation between
localization tests, which are designed to determine the site of urinary
tract infection, and symptoms of upper urinary tract infection. One
explanation is that microorganisms may be present in the kidney but not
initiate an inflammatory response with associated symptoms. An animal
model has been developed to obtain quantitative information on the
comparative pathobiology of lesion-inducing and non-lesion-inducing
infections. In this model, non-manipulated kidneys had acquired a
persistent microbial flora within 48 hours of the lower urinary tract
becoming infected. This bacterial invasion was not associated with
gross or histologic changes within the renal parenchyma, but minor foci
of inflammatory cells were seen beneath the epithelium lining the
calyces. Ureteric urines from such kidneys contained many leukocytes
and high numbers of bacteria. These results showed that the kidneys
were infected, rather than colonized, and the term 'subclinical"
infection was appropriate. Antimicrobial agents were variably success-
ful at eradicating the infection. These experimental observations sup-
port the concept of subclinical pyelonephritis and may explain the
absence of symptoms in the clinically equivalent situation in humans.
Studies of patients with significant bacteriuria, who have
undergone ureteric catheterization or bladder washout tests
have shown that in 30 to 60% of cases, bacteriuria originates in
the upper urinary tract [1—5]. The same studies have also
demonstrated a poor correlation between upper urinary tract
localization and appropriate clinical symptoms. The suggestion
has therefore been made that clinical manifestations of acute
pyelonephritis are determined by factors other than bacterial
invasion of the kidney per se. For example, renal tissue may
often be colonized rather than infected and invading microor-
ganisms may fail to stimulate the inflammatory response asso-
ciated with symptomatic infections, Clinically it is important to
differentiate between individuals with asymptomatic bacterial
invasion of the upper urinary tract and those with cystitis. The
clinical and laboratory findings are similar in these two groups,
but in cystitis, the infectious process is limited to the lower
urinary tract. Although the term "subclinical pyelonephritis"
adequately describes the symptomless bacterial invasion of the
renal parenchyma, there are insufficient details of its natural
history available for it to be accepted as a clinical entity.
Because of the considerable difficulties involved in obtaining
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this information from clinical studies, the present investigation
was undertaken to develop and characterize an animal model of
subclinical pyelonephritis.
Methods
Animals
Adult male and female Hooded Oxford (HO) rats, three to
four months old and weighing between 200 and 250 grams were
used in these experiments.
Bacterial strain
The strain of Escherichia coil 075 employed in these exper-
iments was the same as that used in previous studies of
experimentally induced urinary tract infection [6, 7].
Bacteriologic analysis
Acute pyelonephritis was induced in the left kidney of 70
anesthetized Hooded Oxford (HO) rats, by the direct innocu-
lation of l0 E. co/i 075 into the surgically exposed kidney using
a glass microcapillary pipette. The inoculum was delivered in 5
1.d amounts into two sites in the poles of the kidney [8]. Because
of the absence of vesico-ureteric valves in the rat, reflux of
infected urine occurs, and, in this strain, leads to bacterial
localization in the contralateral kidney. The animals were
housed under standardized conditions without any additional
manipulations. Autopsies were carried out on seven groups of
10 animals at regular intervals over the following 60 days.
Microbial numbers were then quantified in the directly chal-
lenged kidneys with classic pyelonephritis and in the non-
manipulated (right) kidneys. The kidneys were removed asep-
tically, decapsulated and weighed, then homogenized in 9 ml of
normal saline using a rotating PTFE pestle in a heavy-walled
glass tube. Serial tenfold dilutions of the homogenate were then
made in normal saline and Columbia agar (Gibco Laboratories,
Life Technology Inc., Madison, Wisconsin, USA) pour plates
were prepared to determine the bacterial numbers per gram of
renal tissue,
Comparative pathology
Pyelonephritis was induced in the left kidney of 66 HO rats
which were divided into three groups and sacrificed 7, 30 or 60
days later. At autopsy both directly challenged and non-manip-
ulated kidneys were examined for gross and histopathologic
changes. The gross pathology of each kidney was quantitated
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Table 1. Dosages and pharmacologic parameters of antimicrobial agents
Antibiotic
MIC
p.g/ml Dose Route Frequency
Peak concentration
Serum Urine Tissue
Ampicillin 1.6 50 mg/kg i.m. 2 x daily 25 g/ml 400 pg/mI 40 pg/g
(Ampicyn)
Gentamicin 1.6 7.5 mg/kg i.m. 2x daily 8 pg/mla 40 pg/ml 45 pg/g
(Garamicin)
Cotrimoxazole 0.25 50 mg/kg p.o. 2 x daily Trim 3 pg/mI Trim 300 pg/mI Trim 22 pg/g
(Bactrim) Sulpha 4 pg/mI" Suipha 20 pg/ml Sulpha 2.4 pg/g
Ceftriaxone 0.1 200 mg/kg i.m. Daily 160 pg/mlC NA NA
(Rocephin)
Ciprofloxacin 0.02 20 mg/kg p.o. 2x daily 2.5 pg/mI" 345 pg/mI 4 pg/g
(Ciproxin)
Aztreonam 0.1 20mg/kg i.m. 2x daily 38 pg/mla 632 pg/mI 190 sg/g
(Azactam)
Trimethoprim NA 10 mg/kg p.o. 2x daily 3 pg/mlb 300 pg/mI 22 pgIg
(Triprim)
NA is not available.
a Author's unpublished datab Reeves [lii
Glauser and Bonard [12]d Campoli-Richards et al [13]
using a computer program, written in BASIC and installed on a
National Panasonic RL-H7000W PC. The program produces
two mirror image kidney profiles on the screen, representing
both sides of one kidney. The dimensions of the profiles were
scaled to those of the normal rat kidney and a grid was
superimposed onto each kidney to aid orientation. Using a
computer mouse, the scarred areas on the excised kidneys were
shaded in on the screen. The software then calculated the size
of the shaded (scarred) areas on both screen profiles and
expressed this as a percentage of the total kidney surface area.
Kidneys for light microscopic examination were placed in 0.1%
cetylpyridinium chloride in 10% formaldehyde. After routine
processing, 7 to 10 p. thick sections were prepared and stained
with hematoxylin and eosin. The lesion size was determined
using a paper profile of each kidney section on which was
recorded the area of tissue showing histopathologic evidence of
damage. The mean proportion of section occupied by lesions
was calculated in eight representative sections by computer-
graphic analysis as detailed above.
Microbial distribution
Twenty-four animals were challenged in the left kidney as
above, and six animals each sacrificed 7, 14, 30 and 60 days
later. Each kidney was removed and placed in a petri dish, on
a thin bed of solidified wax (Paraplast, Sherwood Medical Fig. 1. Diagrammatic representation of the procedure used for kidneyIndustries, St. Louis, Missoun, USA). Molten wax was then dissection. Each kidney yielded approximately 40 pieces, each weigh-
poured over the entire kidney and allowed to solidify. A single ing on average, 25 mg.
edged razor blade was used to make five cuts along the length of
the kidney to form six slices. Each section was then removed
from the wax bed and laid on the flat surface of the wax. The
slices of tissue were further dissected, each cut from top to tube. The homogenate was then poured onto a Columbia agar
bottom into portions weighing between 10 and 40 mg, so that in pour plate mixed with molten agar, and the total number of
total, each kidney was divided into 30 to 40 pieces (Fig. 1). bacteria determined in each portion. This was expressed as a
Segment numbers were then recorded on a paper profile and percentage of the total number of bacteria in the whole kidney
individual portions weighed and homogenized in I ml of normal and marked on a paper profile. For graphic presentation, 2% of
saline using a flat bottomed glass rod in a flat bottomed glass the total bacteria was represented as a single dot.
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Histopathologic and electron microscopic evaluation of
bacterial foci in non-manipulated kidneys
Using the dissection procedure described above for bacterial
distribution, focal areas of renal tissue from 16 non-manipulated
kidneys, which had been infected for 7, 14, 30 and 60 days, were
examined histopathologically. Alternate samples of tissue were
taken for bacteriologic analysis and the adjacent pieces placed
in fixative solution for histologic examination. The bacteriologic
data was used to identify foci of bacterial sequestration and the
adjacent tissue samples were processed and examined for
histopathologic changes, using light and electron microscopy.
Fifty-two tissue samples were examined by light microscopy at
five different levels and compared with an equivalent number of
samples from uninfected kidneys. For electron microscopic
examination of bacterial foci in the non-manipulated kidneys,
six animals were challenged in the left kidney and left for 60
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Fig. 4. Quantitative analysis of gross and histopathologic changes in
directly challenged kidneys (left) with classic pyelonephritis and unma-
nipulated right kidneys with subclinical infection.
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Fig. 3. Bacterial and leukocyte numbers in ureteric urine from unma-
nipulated right kidneys colonized with E. coli. Samples were obtained 7,
30 and 60 days after challenge.
days without any further manipulation. A bacterial focus was
identified as above in the contralateral kidneys, adjacent areas
fixed in 2.5% glutaraldehyde in 0.1 Mphosphate buffer at pH 7.4
and processed as previously described [91.The 70 to 90 nanom-
eter thick sections were examined in a Philips 4IOLS transmis-
sion electron microscope.
Bacteriologic and cytologic content of ureteric urine
E. coli renal infection was established in the left kidney of 36
HO rats, which were then divided into three equal groups. No
further manipulations were carried out until cannulae were
placed in ureters draining the right kidney 7, 30 and 60 days
later. Ureteric catheters were also placed in 25 normal animals.
Ureteric urine was collected from animals as previously de-
scribed [10]. Urine was collected (1 to 2 ml) into tubes packed
in ice from anesthetized animals over a period of four to six
hours. Samples were examined promptly at the completion of
the experiment. Quantitative bacteriologic analysis was carried
out using serial dilutions of the sample spread on MacConkey
agar plates (Difco Laboratories, Detroit, Michigan, USA) con-
taining crystal violet and 1% lactose. Total leukocyte numbers
were determined in a wet preparation using a hemocytometer.
Antimicrobial therapy
The minimum inhibitory concentrations of each antimicrobial
to the strain of E. co/i 075 used to establish infection were
determined before use. A standard bacterial inoculum was
added to a series of tubes containing a decreasing amount of the
agent in broth and the effect on the bacterial growth observed.
Antibiotic sensitivity, using the disk method of testing, was also
carried out and the size of the zone of inhibition determined for
each antibiotic. A dose was then chosen for each antibiotic that
gave blood, urine and tissue levels of antibiotic in experimental
animals comparable to those found clinically. The source of this
information and the doses used experimentally are shown in
Table 1 [11—131. The left kidneys of eight groups often animals
were challenged as described above. Seven of the groups were
treated for ten days with the appropriate antibiotics commenc-
ing 30 days after challenge. Ureteric catheters were inserted in
the right ureters, two days after the final dose of the antibiotic
and samples collected over a period of several hours. Bacteri-
ologic examination of the urine was carried out as described
previously. The animals were then sacrificed and the unmanip-
ulated kidneys removed for bacteriologic evaluation as detailed
above. Residual inhibition was occasionally noted in animals
treated with gentamicin so homogenates of tissue from these
animals were washed twice with saline before being subjected
to bacteriologic analysis.
Statistical analysis
Data were analyzed using Wilcoxon's sum of ranks method
for non-parametric data.
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A Classical pyelonephritis
Fig. 5. Bacterial distribution, over a 60 day period, in kidneys with (A) classicpyelonephritis and (U) subclinical pyelonephritis. The area of lesion
formation is shown on kidneys that were directly challenged. Each dot represents 2% of the total bacterial isolated from the kidney (represented
as log10 numbers in triangles).
Results
Bacteriologic status of directly challenged and non-
manipulated kidneys
Bacterial numbers in the directly challenged (left) kidneys,
reached a peak at 24 hours and thereafter declined slowly over
the following week to reach a stable population of lO to lO
bacteria per gram of tissue. Contralateral kidneys were some-
times colonized within 24 hours, but by three days, microbial
invasion had occurred. Bacterial numbers were maintained at a
constant level, but in a few kidneys, spontaneous clearance
occurred (Fig. 2).
Bacteriologic and cytologic content of ureteric urine
Seven days after challenge of the left kidney, high bacterial
counts were found in the right ureteric urine from 8 of 12
animals examined (Fig. 3). Leukocytes were present in 11/12 of
the ureteric samples. Ureteric urine draining right kidneys,
examined 30 and 60 days later, showed a similar incidence of
..
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infection to that found at seven days, although absolute bacte-
rial numbers were reduced. In contrast there was a substantially
higher number of leukocytes in the ureteric urine after 30 and 60
days, than at seven days. Ureteric samples from all untreated
control animals were sterile and free of leukocytes.
Comparative pathology
Kidneys which had been directly challenged (classic pyelo-
nephritis) all showed characteristic cortical lesions on gross
examination (Fig. 4). These were seen to be wedge-shaped
areas which traversed the cortex, medulla and renal pelvis.
Early lesions consisted of interstitial foci of neutrophils with
some macrophages and the tubules and collecting ducts were
filled with leukocytes and necrotic debris. After three to four
weeks, the lesions showed an infiltrate of chronic inflammatory
cells, tubular destruction and glomerular crowding. No surface
lesions were apparent on the contralateral unmanipulated kid-
neys and the renal parenchyma was histologically normal in
most cases (33 of 36 kidneys). In three kidneys, evidence of an
inflammatory response was seen as an intraluminal aggregation
of neutrophils in a single tubule. However, minor changes were
commonly observed in the mucosa lining the calyx. Localized
inflammatory foci containing neutrophils and lymphocytes were
present within the transitional cell epithelium and also in the
subepithelial tissues. These lesions were first identified after
seven days and showed a progression over 60 days towards
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multiple small subepithelial collections of lymphocytes, approx-
imately 1 mm in diameter.
Bacterial localization in classic and subclinical pyelonephritis
Microorganisms were usually found in focal aggregates in the
directly challenged kidneys with classic pyelonephritis. The
foci were mainly in the area of the gross lesion, up to 30 days
after challenge but thereafter they were more evenly distributed
(Fig. 5A). In the unmanipulated kidneys, microorganisms were
commonly spread evenly throughout the kidney, but focal
aggregates were occasionally observed (Fig. 5B).
Histopathologic evaluation of bacterial foci in subclinical
pyelonephritis
Areas of the renal parenchyma containing bacterial foci
appeared normal when examined by light microscopy. How-
ever discrete focal areas of the renal calyx showed evidence of
infiltration by neutrophils, lymphocytes and plasma cells be-
neath the transitional epithelium. Electron microscopy of cor-
tical and medullary regions within bacterial foci showed mild
vascular congestion, occasional neutrophilic leukocytes and a
small increase in mononuclear cells, predominantly lympho-
cytes. Occasionally there was evidence of parenchymal cell
injury in the form of cytoplasmic vacuolation, mitochondrial
inclusions and mitochondrial swelling. Fibrin and calcification
within some renal tubules was also present. Samples taken from
similar areas of the kidney in uninfected animals, showed no
evidence of these changes.
Antimicrobial therapy
Bacterial numbers in the right kidneys of animals with
subclinical pyelonephritis treated with ampicillin, cotrimox-
azole, ciprofloxacin, ceftriaxone and gentamicin were signifi-
cantly reduced compared to untreated animals. However only
ceftriaxone and ampicillin were able to sterilize 50% or more of
the kidneys. Trimethoprim and aztreonam had no effect. Ure-
teric urine was effectively sterilized by ampicillin and ceftriax-
one. Ciprofloxacin, gentamicin and cotrimoxazole were suc-
cessful in 60 to 70% of cases, but bacterial numbers were not
affecte4 by trimethoprim and aztreonam (Fig. 6). No differences
in antimicrobial sensitivity were demonstrated when isolates
obtained from animals, which failed to respond to antimicrobial
therapy, were compared with the parent strain.
Discussion
Problems in correlating the bacteriologic status of the in-
fected kidney with functional and pathologic changes has made
the natural history of renal infection in man a difficult topic to
study. Nonetheless, recent reports, which have taken into
account revised criteria for the bacteriologic, histopathologic
and anatomic diagnosis of urinary tract infection (UT!) [14, 15],
the contribution of reflux nephropathy to renal scar formation
[16] and long term outcome for individuals with recurrent UT!
[17—21], suggest that a pattern is emerging. One consistent
observation to come from the studies of patients with proven
UTI has been that bacteriuria could be localized to the upper
urinary tract in over half the cases. However, there was a poor
correlation between bacterial invasion of the upper urinary tract
and the presence of corresponding symptoms of pyelonephritis
[1—51. The reasons why a "level" diagnosis based on the
bacteriologic and cytologic analysis of ureteric samples might
not coincide with the clinical presentation have never been
clear, although some studies suggest that autonomic neuropa-
thy may prevent the expression of renal symptoms [221. Our
belief, based on the results of the present study, is that
microbial invasion of the upper urinary tract sometimes occurs
without the development of classic pyelonephritis. In this
situation, microorganisms establish a presence in the kidney but
fail to stimulate an inflammatory response of sufficient intensity
to generate clinical symptoms. Once invaded, such kidneys
maintain a substantial microbial population for many weeks and
continue to excrete leukocytes in the ureteric urine. However
this invasion is not associated with the gross changes normally
found in experimentally induced renal infection [8, 231, and
histologic evidence of bacterial invasion is limited to micro-
scopic foci of acute inflammation in the epithelial lining of the
calyx. In the absence of morphologic evidence of infection,
these unmanipulated kidneys were initially considered to be
"colonized", rather than infected. However the consistent
demonstration of leukocytes in ureteric urine draining the
non-manipulated kidneys suggested that microbial invasion of
the renal parenchyma was viewed by the host as an infectious
challenge rather than bacterial colonization. The term subclin-
ical pyelonephritis is therefore an appropriate description of an
event involving a cellular response by the host to microbial
invasion of the kidney that does not induce lesions typically
associated with symptomatic infection.
A number of investigators, dating back to Box in 1908 [24]
and Thomsen-Walker in 1926 [25] have noted the discrepancies
between the symptoms of urinary tract infection and bacterial
localization within the urinary tract. They concluded that
factors other than the site of infection determine symptoms.
Our hypothesis was that symptoms of upper UTI are related to
pathologic changes resulting from the host response to micro-
bial invasion of the kidney and not to upper tract localization
per Se. Experimental studies [26], and a clinical report which
demonstrated a close association between significant bacteri-
uria, upper UT! symptoms and laboratory evidence of lesion
formation, support this belief [27]. There is also an increasing
awareness that the full spectrum of the interaction between host
and pathogen in renal infection has yet to be described. Com-
ments by Komaroff [281 and Stamm et al [29], drawing attention
to a group of patients who present with symptoms of acute
cystitis, but in reality have early 'occult" renal infection, are
consistent with the view that bacterial invasion of the kidney
does not necessarily lead to clinical pyelonephritis. This con-
cept is in keeping with the present finding that similar numbers
of microorganisms in the directly challenged and unmanipulated
contralateral kidneys are associated with widely differing de-
grees of tissue damage.
Recent experiments designed to provide a molecular expla-
nation for differences in the ability of microorganisms to invade
renal tissue have indicated that the DNA sequences encoding
for the gal-gal pili are critical determinants and that bacteria
which express these genes persist longer in the kidney than
isogenic strains which lack the adhesins. For renal invasion to
occur, there is also a requirement for virulence factors [30]. The
current study showed that, even in the same animal, a single
A Renal tissue
B Ureteric urine
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microbial strain induced lesions characteristic of classic pyelo-
nephritis in one kidney but minimal changes, consistent with
subclinical infection, in the other. These observations, together
with those of Lomberg et at, who found similar characteristics
among strains of E. coli causing pyelonephritis in children with
and without renal scarring [31], suggest that host factors as well
as microbial characteristics, determine the outcome of bacterial
invasion of the kidney.
Recognition that the kidney can be subclinically infected has
important implications for antimicrobial therapy. A recent
review of the management of acute bacterial cystitis, with and
without evidence of upper urinary tract involvement, indicated
that both ampicillin and co-trimoxazole can provide effective
therapy when infection is confined to the lower urinary tract. In
contrast, treatment is ineffective when the upper urinary tract
was involved [29]. The importance of successful management of
subclinical pyelonephritis has been emphasized by Clark et at
[321, who showed that infection-associated abnormalities of
renal function are reversible if the microorganisms are eradi-
cated. Failure to recognize persistent subclinical infection could
explain why the management of cystitis has a 10 to 15% failure
rate and a high incidence of recurrent infection [33, 34]. Thus
both clinical and experimental studies indicate that an effective
antimicrobial regimen for subclinical pyelonephritis has yet to
be established and reinforces the need for aggressive therapy
once bacterial invasion of the kidney is suspected.
The aim of the present study was to provide experimental
evidence for the concept of subclinical pyelonephritis. Cur-
rently this diagnosis is made on the basis of clinical evaluation
and localization tests, but there is no practical way of reaching
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such a diagnosis at the initial visit. If subclinical pyelonephritis
is to be diagnosed promptly, non-invasive diagnostic proce-
dures will need to be developed and shown to be reliable. The
possibilities for this include quantification of urinary cytokines
[35—371, renal enzymes [38], urinary immunoglobulin levels
[39], renal antigens [40, 411, and concentrating capacity [42].
The availability of the model of subclinical pyelonephritis
characterized in the present study should prove useful in
developing more effective means for its diagnosis and treat-
ment.
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